Overweight and obesity are associated with the development of many serious diseases and health conditions including hypertension.1-7 Risk estimates suggest that 65% to 75% of essential hypertension in adults is related to overweight and obesity.8-11 For example, the Framingham Offspring Study followed 4,294 adults ages 20 – 49 years for eight years.10 The study found a risk estimate of essential hypertension attributable to excess weight and visceral obesity of 77.9% in men and 64.4% in women.10 In the Framingham Heart Study, 9,845 normotensive adults (mean age 52 years) were followed from 1978 to 1994 and assessed at four-year intervals. The study concluded that a 5% weight gain raised the odds of developing hypertension by 20% to 30%.12
A 2009 meta-analysis of four studies found statistically significant associations between overweight (body mass index [BMI] ≥25 – 29.9) and hypertension.6
- Overweight: incidence rate ratio [IRR] 1.28, 95% confidence interval [CI] [1.10 – 1.50] for men and IRR 1.65, 95% CI [1.24 – 2.19] for women
- Obesity: IRR 1.84, 95% CI [1.51 – 2.24] for men and IRR 2.42, 95% CI [1.59 – 3.67] for women
Okosun et al. used data from the third US National Health and Nutrition Examination Surveys (1988 – 1994) to estimate the prevalence of abdominal obesity and its association with hypertension.13 They found the risk of hypertension to be two to three times higher in this population than in people with normal waist size. Abdominal obesity was defined as waist circumference (WC) ≥102 cm for men and WC ≥88 cm for women. Hypertension was defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or current treatment with an antihypertensive medication. This study found that the population attributable risk for hypertension in people with abdominal obesity was:
Race/Ethnicity
|
Men
|
Women
|
Black
|
21.0%
|
38.4%
|
White
|
27.3%
|
36.5%
|
Hispanic
|
20.9%
|
55.6%
|
Total
|
25.3%
|
51.1%
|
Obese people have excess adipose tissue that requires increased blood flow to support it.11,14 This increase is not limited to the excess tissue. Obesity results in an increased total blood volume, stroke volume, and cardiac output, while peripheral vascular resistance is increased.11,14-16 Obese people often have insulin and leptin resistance which can lead to sodium retention which contributes to the hemodynamic dysfunction and elevated blood pressure. In obese people, the heart rate itself is usually not increased so the higher cardiac output is mainly managed by a higher stroke volume. This results in increased filling pressure and volume. This increased blood pressure further contributes to heart damage including left ventricular dilation, wall stress, and hypertrophy. It can also cause the left atrium to enlarge. The kidneys may also be damaged by the increased pressure.
Obese adults have at least a 20% higher risk of death than normal weight adults from cardiovascular disease (CVD) and all other causes.3 Obese adults may die earlier from CVD causes than people with normal weight, ranging from 1.6 years early (95% CI [0.1 – 3.1]) for mildly obese to 5.0 years early (95% CI [1.7 – 8.4]) for severely obese (BMI ≥40) people.3 A 2009 analysis of US nationally representative health surveys, such as NHANES 2003-2006, and US disease-specific mortality statistics found that about one in ten deaths in the US, or about 216,000 adults (95% CI [188,000 – 237,000]) could be attributed to overweight and obesity.4
Definition of Overweight and Obesity
Overweight and obesity were most recently defined in the 2013 guidelines for the management of overweight and obesity in adults by The Obesity Society and American College of Cardiology/American Heart Association (ACC/AHA).5 Overweight is defined as a BMI of 25.0 to 29.9 and obesity as a BMI of ≥30 [Strong Recommendation (Level B)]. BMI is a measure that adjusts body weight for height.
An Adult BMI Calculator is available from the US Centers for Disease Control and Prevention.17 It is for people 20 years old or older.
References
- Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 2016; 22 Suppl 3: 1-203.
- Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics - 2018 update: a report from the American Heart Association. Circulation 2018; 137 (12): e67-e492.
- Borrell LN, Samuel L. Body mass index categories and mortality risk in US adults: the effect of overweight and obesity on advancing death. Am J Public Health 2014; 104 (3): 512-519.
- Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009; 6 (4): e1000058.
- Expert panel report: guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring) 2014; 22 Suppl 2: S41-410.
- Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88.
- Strazzullo P, D'Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010; 41 (5): e418-426.
- Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23 (11): 1170-1178.
- Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282 (16): 1523-1529.
- Garrison RJ, Kannel WB, Stokes J, 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16 (2): 235-251.
- Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 2015; 116 (6): 991-1006.
- Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358 (9294): 1682-1686.
- Okosun IS, Prewitt TE, Cooper RS. Abdominal obesity in the United States: prevalence and attributable risk of hypertension. J Hum Hypertens 1999; 13 (7): 425-430.
- DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nature reviews Endocrinology 2014; 10 (6): 364-376.
- Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014; 63 (14): 1345-1354.
- Zhang R, Reisin E. Obesity-hypertension: the effects on cardiovascular and renal systems. Am J Hypertens 2000; 13 (12): 1308-1314.
- Centers for Disease Control and Prevention. Healthy weight: adult BMI calculator. 2015; https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/english_bmi_calculator/bmi_calculator.html. Accessed 28 Apr 2018.